Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALECTINIB vs ALEMTUZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALECTINIB vs ALEMTUZUMAB: Safety Overview

Metric ALECTINIB ALEMTUZUMAB
Total FAERS Reports 9,161 14,161
Deaths Reported 1,055 1,417
Death Rate 11.5% 10.0%
Hospitalizations 1,553 4,455
Average Patient Age 60.7 yrs 38.9 yrs
% Female Patients 60.2% 63.2%
FDA Approval Date Dec 11, 2015 N/A
Manufacturer Genentech, Inc. Genzyme Corporation
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription